A company spokesman told FoodProductionDaily.com: “Customized manufacturing applies to a wide range of culture media formulation such as LX broth used for selective enrichment of Listeria before detection, Hektoen agar used for the selective growth and isolation of Salmonella and Shigella or ChromID 0157:H7 for selective growth and isolation of E.coli O157:H7.”
Compromise food safety
The culture media are used in the food and beverage sectors to detect pathogenic micro organisms that could compromise food safety or quality.
Alexandre Merieux, corporate vice president said: “This newly created facility enables us to satisfy our customers’ increasing needs for flexibility and special batch sizes to complement our standard product range.”
A wide degree of flexibility in packaging, volume and media formulation is necessary to allow agri-food and biopharmaceutical companies to meet their customers’ demands for demanding quality requirements, he added.
The new plant in south-eastern France, where the company’s main culture media production is located, will allow the supply of very specific culture media regardless of the batch size to be produced.
New production unit
“Custom manufacturing is already possible at several BioMerieux sites,” said a company statement. “The creation of this new production unit heralds an important new step in the company’s commitment to improving consumer satisfaction.”
The culture media can be supplied in tubes, plates or bottles.
The company’s products are validated and produced in compliance with ISO 9001 and Good Manufacturing Practice standards, it said.
In addition to advising customers on the most appropriate microbiological solution, the company said it can offer scientific support to facilitate product validation on customers’ own premises.